Johnson & Johnson Innovation – JJDC — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Accent Therapeuticsaccenttx.comin𝕏Jan 2024
Accent Therapeutics is a biotechnology company focused on discovering and developing small molecule drugs to improve health outcomes for cancer patients.
BiotechHealthtechLongevity
Co-investorsAtlas VentureDroia VenturesEcoR1 CapitalGV (Google Ventures)The Column GroupJJDC+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.